Biogen’s Alzheimer’s Drug Aduhelm Has Another Shot at Success

Illustration by Elias Stein Text size Biogen ’s Alzheimer’s disease therapy, Aduhelm, has been a disappointment for the company since its Food and Drug Administration approval last spring, with early ...

Deere Goes Autonomous With Its Farmer-Free Tractor

Illustration by Elias Stein Text size One of the biggest themes at this past week’s CES tech show was electric and autonomous transportation—cars, trucks, bikes, boats. And, it turns out, tractors. Fa...

5 Companies That Began 2022 With Upbeat News on Dividends

Royalty Pharma, Life Storage, and Viatris, among other companies, rang in 2022 by announcing dividend increases this week. Royalty Pharma (ticker: RPRX) declared a quarterly dividend of 19 cents a sha...

Buy Deere Stock Because It’s the Tesla of Farming

Text size Deere stock is a buy, Baird says. Justin Sullivan/Getty Images Deere stock had a banner 2021. Baird analyst Mig Dobre sees more gains for investors in 2022. Self-driving tractors are a key t...